Delivery Order SPE2DB20D3103-SPE2DB26FL5H5
- Not listed
- The Defense Logistics Agency awarded a $10,372.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on November 7, 2025, with a ceiling value of $1,563.52 and an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $5,810.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of MULTAQ 400 mg tablets (60-count units). This non-set-aside competitive award is scheduled for completion by October 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $19,348.64 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count) on September 15, 2025, with completion due by September 16, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on October 22, 2025, with a ceiling value of $8,234.43 and an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under AmerisourceBergen's broader relationship with DLA's medical supply chain. The contract involved no set-aside designation, indicating open competition...
- The Defense Logistics Agency awarded a $44,277.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.00 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,247.47. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which supplies pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract valued at $3,059.76. The order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5H5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,477.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages). This firm fixed price delivery order, which must be completed by November 7, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent performance under such vehicles demonstrates its capability to meet federal medical procurement requirements and supply critical medications across multiple therapeutic domains to support defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 11/6/25 |